Conference Coverage

Conference Coverage

LCZ696 surpasses enalapril for heart failure

Key clinical point: Substituting LCZ696 for enalapril in heart failure patients was linked with significant improvements in survival, heart...

Conference Coverage

SIGNIFY: Ivabradine no help in stable CAD

Key clinical point: The investigational drug ivabradine did not improve outcomes in stable CAD patients with no heart failure.Major finding: No...

Conference Coverage

Darapladib flunks another phase III trial

Key clinical point: Darapladib failed to improve cardiovascular outcomes after acute coronary events.Major finding: After 2.5 years, there was no...

Pages